One study found a statistically almost significant increase in visceral adipose tissue (VAT) in the rosiglitazone group when compared to placebo [ 60 ], while there were no significant changes in VAT between the glitazone and placebo arms in the other studies.
← all excerpts
The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients.
1
—
—